Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

Moderna said the 2025-2026 formula of its Covid-19 vaccine produced a strong immune response against the dominant LP.8.1 variant. The company said a preliminary analysis from a phase four clinical ...

If you're not over 65 or have certain risk factors, it might be hard to get one but not necessarily impossible. Here's what ...

Moderna's updated Spikevax shows strong antibody response and safety, targeting dominant COVID-19 variants like LP.8.1 in ...

Recent CDC data show that that wastewater SARS-CoV-2 detections are high and that LP.8.1 and related strains XFG and NB.1.8.1 ...

The “newly approved sources of authority” include the American College of Obstetricians and Gynecologists (ACOG), the ...

Moderna says the first trial volunteers have received boosters of their vaccine, some of them modified to target a variant. Moderna announced Wednesday that the first trial volunteers have received ...

Speaking at a WIRED event Tuesday, Moderna CEO Stéphane Bancel said he was “encouraged” by the company’s dialogue with the ...

Pfizer and Moderna on Wednesday defended their COVID-19 vaccines as having saved millions of lives worldwide, in separate ...

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its ...

Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to ...

Moderna shares were down 7.4% Friday—their lowest level since March 2020. The drop brought the drugmaker’s year-to-date slump ...